References
- Greene FL, Page DL, Fritz A, Balch CM, Haller DG, Morrow M. AJCC cancer staging manual. 6th ed. New York: Springer- Verlag; 2002.
- Myers JN, Greenberg JS, Mo V, Roberts D. Extracapsular spread: a significant predictor of treatment failure in patients with squamous cell carcinoma of the tongue. Cancer 2001;92:3030-6. https://doi.org/10.1002/1097-0142(20011215)92:12<3030::AID-CNCR10148>3.0.CO;2-P
- Liao CT, Chang JT, Wang HM, et al. Analysis of risk factors of predictive local tumor control in oral cavity cancer. Ann Surg Oncol 2008;15:915-22. https://doi.org/10.1245/s10434-007-9761-5
- Liao CT, Wang HM, Chang JT, et al. Analysis of risk factors for distant metastases in squamous cell carcinoma of the oralcavity. Cancer 2007;110:1501-8. https://doi.org/10.1002/cncr.22959
- Martinez-Gimeno C, Rodriguez EM, Vila CN, Varela CL. Squamous cell carcinoma of the oral cavity: a clinicopathologic scoring system for evaluating risk of cervical lymph node metastasis. Laryngoscope 1995;105:728-33. https://doi.org/10.1288/00005537-199507000-00011
- Ng SH, Yen TC, Chang JT, et al. Prospective study of [18F] fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck. J Clin Oncol 2006;24:4371-6. https://doi.org/10.1200/JCO.2006.05.7349
- Ng SH, Yen TC, Liao CT, et al. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation. J Nucl Med 2005;46:1136-43.
- Kunkel M, Forster GJ, Reichert TE, et al. Detection of recurrent oral squamous cell carcinoma by [18F]-2-fluorodeoxyglucosepositron emission tomography: implications for prognosis and patient management. Cancer 2003;98:2257-65. https://doi.org/10.1002/cncr.11763
- Kunkel M, Forster GJ, Reichert TE, et al. Radiation response non-invasively imaged by [18F]FDG-PET predicts local tumor control and survival in advanced oral squamous cell carcinoma. Oral Oncol 2003;39:170-7. https://doi.org/10.1016/S1368-8375(02)00087-8
- Hofele C, Freier K, Thiele OC, Haberkorn U, Buchmann I. High 2-[18F]fluoro-2-deoxy-d-glucose (18FDG) uptake measured by positron emission tomography is associated with reduced overall survival in patients with oral squamous cell carcinoma. Oral Oncol 2009;45:963-7. https://doi.org/10.1016/j.oraloncology.2009.06.008
- Kim SY, Roh JL, Kim JS, et al. Utility of FDG PET in patients with squamous cell carcinomas of the oral cavity. Eur J Surg Oncol 2008;34:208-15. https://doi.org/10.1016/j.ejso.2007.03.015
- Liao CT, Chang JT, Wang HM, et al. Pretreatment primary tumor SUVmax measured by FDG-PET and pathologic tumor depth predict for poor outcomes in patients with oral cavity squamous cell carcinoma and pathologically positive lymph nodes. Int J Radiat Oncol Biol Phys 2009;73:764-71. https://doi.org/10.1016/j.ijrobp.2008.05.004
- Liao CT, Chang JT, Wang HM, et al. Preoperative [18F]fluorodeoxyglucose positron emission tomography standardized uptake value of neck lymph nodes predicts neck cancer control and survival rates in patients with oral cavity squamous cell carcinoma and pathologically positive lymph nodes. Int J Radiat Oncol Biol Phys 2009;74:1054-61. https://doi.org/10.1016/j.ijrobp.2008.09.045
- Liao CT, Wang HM, Huang SF, et al. PET and PET/CT of the neck lymph nodes improves risk prediction in patients with squamous cell carcinoma of the oral cavity. J Nucl Med 2011;52:180-7. https://doi.org/10.2967/jnumed.110.082370
- Suzuki H, Hasegawa Y, Terada A, et al. FDG-PET predicts survival and distant metastasis in oral squamous cell carcinoma. Oral Oncol 2009;45:569-73. https://doi.org/10.1016/j.oraloncology.2008.07.009
- Berghmans T, Dusart M, Paesmans M, et al. Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project. J Thorac Oncol 2008;3:6-12. https://doi.org/10.1097/JTO.0b013e31815e6d6b
- Halfpenny W, Hain SF, Biassoni L, Maisey MN, Sherman JA, McGurk M. FDG-PET: a possible prognostic factor in head and neck cancer. Br J Cancer 2002;86:512-6. https://doi.org/10.1038/sj.bjc.6600114
- Juweid ME. Utility of positron emission tomography (PET) scanning in managing patients with Hodgkin lymphoma. Hematology Am Soc Hematol Educ Program 2006:259-65,510-1.
- Kang JK, Kim MS, Choi CW, et al. The usefulness of 18F-FDG PET/CT for predicting the response of locally advanced rectal cancer to neoadjuvant chemoradiation therapy. J Korean Soc Ther Radiol Oncol 2009;27:111-9. https://doi.org/10.3857/jkstro.2009.27.3.111
- Kidd EA, Siegel BA, Dehdashti F, Grigsby PW. The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival. Cancer 2007;110:1738-44. https://doi.org/10.1002/cncr.22974
- Kim G, Kim YS, Han EJ, et al. FDG-PET/CT as prognostic factor and surveillance tool for postoperative radiation recurrence in locally advanced head and neck cancer. Radiat Oncol J 2011;29:243-51. https://doi.org/10.3857/roj.2011.29.4.243
- Kim SY, Roh JL, Kim MR, et al. Use of 18F-FDG PET for primary treatment strategy in patients with squamous cell carcinoma of the oropharynx. J Nucl Med 2007;48:752-7. https://doi.org/10.2967/jnumed.107.039610
- Kunkel M, Helisch A, Reichert TE, et al. Clinical and prognostic value of [(18)F]FDG-PET for surveillance of oral squamous cell carcinoma after surgical salvage therapy. Oral Oncol 2006;42:297-305. https://doi.org/10.1016/j.oraloncology.2005.08.004
- Maemura K, Takao S, Shinchi H, et al. Role of positron emission tomography in decisions on treatment strategies for pancreatic cancer. J Hepatobiliary Pancreat Surg 2006;13:435-41. https://doi.org/10.1007/s00534-006-1102-8
- Okada J, Yoshikawa K, Itami M, et al. Positron emission tomography using fluorine-18-fluorodeoxyglucose in malignant lymphoma: a comparison with proliferative activity. J Nucl Med 1992;33:325-9.
- Patronas NJ, Di Chiro G, Kufta C, et al. Prediction of survival in glioma patients by means of positron emission tomography. J Neurosurg 1985;62:816-22. https://doi.org/10.3171/jns.1985.62.6.0816
- Swisher SG, Erasmus J, Maish M, et al. 2-Fluoro-2-deoxy-Dglucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma. Cancer 2004;101:1776-85. https://doi.org/10.1002/cncr.20585
- Suzuki H, Fukuyama R, Hasegawa Y, et al. Tumor thickness, depth of invasion, and Bcl-2 expression are correlated with FDG-uptake in oral squamous cell carcinomas. Oral Oncol2009;45:891-7.
- van Baardwijk A, Dooms C, van Suylen RJ, et al. The maximum uptake of (18)F-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor- 1alpha and GLUT-1 in non-small cell lung cancer. Eur J Cancer 2007;43:1392-8. https://doi.org/10.1016/j.ejca.2007.03.027
- Tian M, Zhang H, Nakasone Y, Mogi K, Endo K. Expression of Glut-1 and Glut-3 in untreated oral squamous cell carcinoma compared with FDG accumulation in a PET study. Eur J Nucl Med Mol Imaging 2004;31:5-12. https://doi.org/10.1007/s00259-003-1316-9
- Kunkel M, Reichert TE, Benz P, et al. Overexpression of Glut- 1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma. Cancer 2003;97:1015-24. https://doi.org/10.1002/cncr.11159
- Kato H, Takita J, Miyazaki T, et al. Correlation of 18-F-fluorodeoxyglucose (FDG) accumulation with glucose transporter (Glut-1) expression in esophageal squamous cell carcinoma. Anticancer Res 2003;23:3263-72.